Tubulin as a Well-Established Yet Underexploited Target: New Opportunities for Drugs Repurposing?
{{output}}
Drug repurposing can accelerate oncology translation by leveraging approved compounds with known pharmacology; success depends on a plausible mechanism for the new indication. The microtubule cytoskeleton is a validated anticancer target, yet tubulin-directed ... ...
